GetPortalImpactFactorByIdResp(projectId=1, id=4a83887, cover=https://img.medsci.cn/images/journal/cover/2021/Lvq_202109271314255160.jpg, fullname=ATHEROSCLEROSIS SUPPLEMENTS, abbr=ATHEROSCLEROSIS SUPP, pyear=2000, frequence=Semiannual, articleNumbers=11, citedSelf2015=34.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1月, reviewFee=null, pageFee=null, publishedRatio=2019年中国人文章占该期刊总数量6.67% (2018年为7.60%), issn=1567-5688, greenSci=https://www.greensci.net/search?kw=1567-5688, scijournal=https://www.scijournal.org/impact-factor-of-ATHEROSCLEROSIS-SUPP.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.908, medsciHotlight=2.501, medsciHotlight5year=3.65674, citescore=4.8, hIndex=50, impactFactor=1.585, orgnization=Elsevier Ireland Ltd, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学4区, smallclassCas=医学 3 区, website=https://www.sciencedirect.com/science/journal/15675688, websiteHits=5627, guideForAuthor=null, guideForAuthorHits=6, submitWebsite=, submitWebsiteHits=5, content=Published by Elsevier Science. ISSN: 1567-5688.<br /><br />Supplement to Atherosclerosis., totalCites=706, brief=ATHEROSCLEROSIS SUPP杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=外周血管病" >外周血管病</a></strong>”子行业的优秀级杂志, articleType=该刊全部是论著，可能不接收综述类等文章, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=ATHEROSCLEROSIS SUPP杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//www.sandwebs.com/sci/submit.do?id=4a83887'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=1750, tagName=动脉硬化, createdHits=1), ImpactFactorTagDto(id=703, tagName=冠心病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.91), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.15), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.1), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.8)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.23), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.318), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.21), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.926), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.908)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Cardiology and Cardiovascular Medicine , rank=91/322), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Internal Medicine , rank=39/120)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PERIPHERAL VASCULAR DISEASE, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5688[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ATHEROSCLEROSIS SUPPLEMENTS[ta], article_number=30, article_number_cn=0, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)